Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: PLoS ONE, 9, 8, S. e104730-
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2014
- Ereignis
-
Veröffentlichung
- (wer)
-
Public Library of Science (PLoS)
- (wann)
-
2014
- Urheber
-
Stotz, Michael
Szkandera, Joanna
Seidel, Julia
Stojakovic, Tatjana
Samonigg, Hellmut
Reitz, Daniel
Gary, Thomas
Kornprat, Peter
Schaberl-Moser, Renate
Hoefler, Gerald
Gerger, Armin
Pichler, Martin
- DOI
-
10.1371/journal.pone.0104730
- URN
-
urn:nbn:de:bvb:384-opus4-1036374
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stotz, Michael
- Szkandera, Joanna
- Seidel, Julia
- Stojakovic, Tatjana
- Samonigg, Hellmut
- Reitz, Daniel
- Gary, Thomas
- Kornprat, Peter
- Schaberl-Moser, Renate
- Hoefler, Gerald
- Gerger, Armin
- Pichler, Martin
- Universität Augsburg
- Public Library of Science (PLoS)
Entstanden
- 2014
Ähnliche Objekte (12)
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Best of ASCO 2022: bladder cancer
Deciphering the role of LINC00261 and FOXA2 in epithelial-mesenchymal transition and metastasis of pancreatic cancer cells
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
Involvement of the long noncoding RNA NEAT1 in carcinogenesis
RNA-binding proteins as important regulators of long non-coding RNAs in cancer
Multi-omics in prognosis of hepatocellular carcinoma
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Best of ASCO 2022: bladder cancer
Deciphering the role of LINC00261 and FOXA2 in epithelial-mesenchymal transition and metastasis of pancreatic cancer cells
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
Involvement of the long noncoding RNA NEAT1 in carcinogenesis
RNA-binding proteins as important regulators of long non-coding RNAs in cancer
Multi-omics in prognosis of hepatocellular carcinoma
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Best of ASCO 2022: bladder cancer
Deciphering the role of LINC00261 and FOXA2 in epithelial-mesenchymal transition and metastasis of pancreatic cancer cells
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
Involvement of the long noncoding RNA NEAT1 in carcinogenesis
RNA-binding proteins as important regulators of long non-coding RNAs in cancer